Abstract

The Section is the statistical and data management component of the Division of Clinical Sciences (DCS). The Section provides statistical leadership and data management consultation for major activities of the Division, and is involved in the design, conduct, monitoring, and statistical analyses of intramural and national multicenter clinical trials of experimental treatments for cancer, and intramural clinical trials for treatment of AIDS. Other major collaborative efforts include studies to identify important prognostic and treatment selection factors, evaluate diagnostic procedures, develop improved staging systems, and assist investigators in the design, execution, and analyses of major in vitro drug testing studies. The Section develops and implements new statistical designs and biometric methods related to the development and evaluation of new cancer and AIDS treatments. The Section maintains computerized data collection systems for intramural and national multicenter clinical protocols, and it works closely with interested branches to improve data recording and retrieval. The Section maintains a unified system for tracking basic information on all patients registered on DCS treatment protocols. Approximately 15% of the Sectionas activities are HIV-AIDS related.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC007202-17
Application #
6433371
Study Section
(BDMS)
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
2000
Total Cost
Indirect Cost

  Institution

Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code

  Publications

Bishop, M R; Dean, R M; Steinberg, S M et al. (2008) Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Ann Oncol 19:1935-40
Berna, Marc J; Annibale, Bruno; Marignani, Massimo et al. (2008) A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab 93:1582-91
Lechleider, Robert J; Arlen, Philip M; Tsang, Kwong-Yok et al. (2008) Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant. Clin Cancer Res 14:5284-91
Gregorc, V; Hidalgo, M; Spreafico, A et al. (2008) Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib. Clin Pharmacol Ther 83:477-84
Norton, Jeffrey A; Venzon, David J; Berna, Marc J et al. (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg 247:501-10
Powell, Anathea C; Stratakis, Constantine A; Patronas, Nicholas J et al. (2008) Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. Surgery 143:750-8
Sportes, Claude; Hakim, Frances T; Memon, Sarfraz A et al. (2008) Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 205:1701-14
Cecchinato, Valentina; Tryniszewska, Elzbieta; Ma, Zhong Min et al. (2008) Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 180:5439-47
Sharifi, Nima; Hamada, Akinobu; Sissung, Tristan et al. (2008) A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU Int 102:617-21
Gril, Brunilde; Palmieri, Diane; Bronder, Julie L et al. (2008) Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 100:1092-103

Showing the most recent 10 out of 127 publications